This remains an actively moving area, however: on February 27, 2026, the HHS Secretary publicly announced an intent to move roughly 14 of the 19 Category 2-listed peptides, reportedly including ipamorelin and CJC-1295, back toward Category 1 status, and multiple industry and legal-news outlets reported further FDA action in the following months easing Category 2-related restrictions on this group of peptides
Starting too high leads to severe GI side effects
Peptide therapy is an emerging medical practice that uses specific peptides, such as BPC-157, to aid tissue repair, improve joint health, increase exercise capacity, and enhance overall health and wellness
Lot numbers: the traceability chain A COA without a lot number is a document without an anchor
Veterinary GMP Certified: Manufactured under strict GMP standards with latest certification updated in 2022